Time to IVT Treatment and Functional Outcomes in Acute Ischemic Stroke-Reply

JAMA. 2024 Jun 18;331(23):2049. doi: 10.1001/jama.2024.7979.

Authors

Johannes Kaesmacher¹, Fabiano Cavalcante², Urs Fischer³

Affiliations

¹ University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Bern, Switzerland.
² Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
³ Department of Neurology, University Hospital Bern, Bern, Switzerland.

PMID: 38776102
DOI: 10.1001/jama.2024.7979

No abstract available

Publication types

Letter
Comment

MeSH terms

Fibrinolytic Agents / therapeutic use
Humans
Ischemic Stroke* / therapy
Stroke / therapy
Thrombolytic Therapy
Time-to-Treatment*
Tissue Plasminogen Activator / therapeutic use
Treatment Outcome

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator